BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2898789)

  • 1. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):29-33. PubMed ID: 2898789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
    Zarrindast MR; Shahed-Dirin K
    Psychopharmacology (Berl); 1990; 100(2):275-80. PubMed ID: 2305016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
    Jackson DM; Ross SB; Hashizume M
    Psychopharmacology (Berl); 1988; 94(3):321-7. PubMed ID: 2895938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    Zarrindast MR; Eliassi A
    Gen Pharmacol; 1991; 22(6):1027-31. PubMed ID: 1687393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age on behavioral responses to dopamine agonists in the rat.
    Ushijima I; Mizuki Y; Soeda K; Kishimoto O; Hara T; Yamada M
    Eur J Pharmacol; 1987 Jun; 138(1):101-6. PubMed ID: 2887433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation by serotonergic inhibition of yawning induced by dopamine receptor agonists in rats.
    Matsumoto S; Yamada K; Nagashima M; Matsuo N; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1989 Mar; 32(3):815-8. PubMed ID: 2525786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of D-1 and D-2 receptors in apomorphine-induced pecking in chicks.
    Zarrindast MR; Amin R
    Psychopharmacology (Berl); 1992; 106(1):67-70. PubMed ID: 1346722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
    Ross SB; Jackson DM; Wallis EM; Edwards SR
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):512-8. PubMed ID: 3261844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.
    Longoni R; Spina L; Di Chiara G
    Eur J Pharmacol; 1987 Feb; 134(2):163-73. PubMed ID: 2883010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
    Jenkins OF; Jackson DM
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):7-11. PubMed ID: 3877878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats.
    Longoni R; Spina L; Di Chiara G
    Life Sci; 1987 Nov; 41(18):2135-45. PubMed ID: 2959833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
    Moody CA; Spear LP
    Psychopharmacology (Berl); 1992; 107(1):39-49. PubMed ID: 1350350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.
    Jackson DM; Jenkins OF
    J Neural Transm; 1985; 62(3-4):219-30. PubMed ID: 3897455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    Zarrindast MR; Minaian A
    Gen Pharmacol; 1991; 22(6):1017-21. PubMed ID: 1687391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.